Nachrichten zur Madrigal Pharmaceuticals Corp. Aktie

Madrigal Pharmaceuticals Hits the NASH Jackpot

A late-stage trial of its drug resmetirom showed a 'best-case dataset' in resolving NASH and improving liver fibrosis....…

Madrigal Pharma Shares Hit 52-Week High After Positive Resmetirom Liver Treatment Trial

Madrigal Pharma Shares Hit 52-Week High After Positive Resmetirom Liver Treatment Trial...…

Madrigal (MDGL), Viking Therapeutics (VKTX) Stocks Surge on ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Madrigal Pharmaceuticals Stock Is Crushing It Today

The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug....…

Thinking about trading options or stock in Madrigal Pharmaceuticals, Amazon, Moderna, Apple, or Baidu?

NEW YORK, Dec. 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MDGL, AMZN, MRNA, AAPL, and BIDU. Click…

Form 8-K MADRIGAL PHARMACEUTICALS For: Dec 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viking Therapeutics stock rallies after Madrigal shares positive data about its liver drug

Shares of Viking Therapeutics Inc. jumped 55% in premarket trading on Monday after a company that is also developing…

Madrigal Pharmaceuticals Shares Triple After Positive Resmetirom Data

Madrigal Pharmaceuticals Shares Triple After Positive Resmetirom Data...…

Madrigals stock rallies about 200% after sharing positive data about its NASH treatment candidate

Shares of Madrigal Pharmaceuticals Inc. soared 209.6% in premarket trading on Monday after the company shared positive data from…

UPDATE 1-Madrigal drug meets main goals in much-awaited NASH trial

...(Adds background) Dec 19 (Reuters) - Madrigal Pharmaceuticals said......…

Madrigal drug meets main goals in much-awaited NASH trial

...(Reuters) - Madrigal Pharmaceuticals said on Monday its......…

Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th

CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing…